Great West Life Assurance CO Heron Therapeutics, Inc. Transaction History

Great West Life Assurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$2.3 - $6.29 $10,655 - $29,141	4,633 New	4,633 $13,000
Q2 2022 Aug 09, 2022	SELL	$2.3 - $6.29 $10,655 - $29,141	-4,633 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$13.27 - $18.48 $19,427 - $27,054	-1,464 Reduced 24.01%	4,633 $72,000
Q4 2019 Feb 11, 2020	BUY	$17.42 - $26.61 $17,594 - $26,876	1,010 Added 19.85%	6,097 $143,000
Q3 2019 Oct 25, 2019	SELL	$16.36 - $21.39 $73,620 - $96,255	-4,500 Reduced 46.94%	5,087 $94,000
Q1 2019 May 08, 2019	BUY	$23.15 - $28.34 $45,744 - $55,999	1,976 Added 25.96%	9,587 $234,000
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $90,480 - $123,203	3,016 Added 65.64%	7,611 $240,000
Q1 2018 May 10, 2018	SELL	$18.43 - $28.8 $95,762 - $149,644	-5,196 Reduced 53.07%	4,595 $127,000
Q4 2017 Feb 09, 2018	BUY	$14.8 - $18.85 $100,625 - $128,161	6,799 Added 227.24%	9,791 $177,000
Q3 2017 Nov 09, 2017	BUY	$14.65 - $16.85 $43,832 - $50,415	2,992	2,992 $48,000

175

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $202M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.